Author response for 'A double-blind, Randomized controlled trial on glucose-lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase-4 inhibitor therapy: REFIND study'
| Autor: | null Ryang, Soree, null Kim, Sang Soo, null Bae, Ji Cheol, null Han, Ji Min, null Kwon, Su Kyoung, null Kim, Young Il, null Nam-Goong, Il Seong, null Kim, Eun Sook, null Kim, Mi-Kyung, null Lee, Chang Won, null Yoo, Soyeon, null Koh, Gwanpyo, null Kwon, Min Jeong, null Park, Jeong Hyun, null Kim, In Joo |
|---|---|
| Rok vydání: | 2022 |
| DOI: | 10.1111/dom.14766/v2/response1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|